BA
SGEN

Bristlecone Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bristlecone Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,300
Closed -$180K – 267
2017
Q3 		$180K Buy
+3,300
New +$169K 0.06% 141
2017
Q2 		– Sell
-3,800
Closed -$239K – 157
2017
Q1 		$239K Sell
3,800
-400
-10% -$25K 0.08% 137
2016
Q4 		$222K Hold
4,200
– – 0.08% 142
2016
Q3 		$227K Buy
+4,200
New +$199K 0.08% 143

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bristlecone Advisors's SGEN Position: Q4 2017 in Review

Bristlecone Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2017, closing a stake of 3,300 shares — an estimated $180K sold.

Bristlecone Advisors first reported a position in SGEN in Q3 2016 and held it in 4 quarters. The position peaked at $239K in Q1 2017. 298 funds tracked by Wall St. Rank hold SGEN as of Q4 2017.

  • Bristlecone Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Bristlecone Advisors sold 3,300 Seagen Inc. Common Stock shares in Q4 2017, an estimated $180K.
  • Bristlecone Advisors first reported a position in Seagen Inc. Common Stock in Q3 2016 and held it in 4 quarters.
  • Bristlecone Advisors's Seagen Inc. Common Stock position peaked at $239K in Q1 2017.
  • 298 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2017.

Based on Bristlecone Advisors's 13F filing for Q4 2017, filed 30 Jan 2018.